You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Latent reservoir

Showing 1 - 25 of 788
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Barcelona (Control group , Experimental group 1 lauric acid, Experimental group 2 lauric acid)

Recruiting
  • HIV Infections
  • Control group placebo
  • +2 more
  • Barcelona, Spain
    Hospital Universitario Vall d´Hebron
Jan 13, 2023

HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)

Recruiting
  • HIV-1-infection
  • BCG Vaccine AJVaccines
  • Zurich, Switzerland
    University Hospital Zurich
Jan 28, 2022

HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)

Completed
  • HIV/AIDS
  • Chidamide with CAR-T or TCR-T cell therapy
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

Immune Activation and Latent HIV Reservoir Size Between People

Enrolling by invitation
  • HIV-1-infection
  • +3 more
  • Venipuncture
  • +4 more
  • Seattle, Washington
    University of Washington Positive Research and the Gastroenterol
Oct 14, 2022

Targeting of the Latent HIV Infected Reservoir to Cure HIV

Recruiting
  • HIV Infections
  • +2 more
    • Rotterdam, Netherlands
      Erasmus Medical Centre
    Jan 17, 2022

    Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)

    Completed
    Has Results
    • Human Immunodeficiency Virus (HIV)
    • Ixazomib 1 MG
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Dec 8, 2021

    HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

    Completed
    Has Results
    • HIV
    • Acute HIV Infection
    • Dolutegravir 50 mg
    • +2 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 22, 2021

    HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

    Terminated
    Has Results
    • HIV Infection
    • Recombinant Interleukin-2
    • Cleveland, Ohio
      AIDS Clinical Trials Unit
    Sep 1, 2022

    HIV-1-infection Trial in Shanghai (Euphorbia kansui Pill)

    Not yet recruiting
    • HIV-1-infection
    • Euphorbia kansui Pill
    • Shanghai, China
      Shanghai,China, Fudan University
    Aug 6, 2020

    Chronic HIV Trial in Xi'an (Chidamide)

    Completed
    • Chronic HIV Infections
    • Xi'an, Shaanxi, China
      Department of Infectious Diseases, Tangdu Hospital, The Fourth M
    Jan 12, 2020

    HIV-1-infection Trial in Aarhus (Venetoclax)

    Not yet recruiting
    • HIV-1-infection
    • Aarhus, Denmark
      Aarhus University Hospital
    Jan 5, 2023

    HIV/AIDS Trial in Guangzhou (Arsenic Trioxide)

    Recruiting
    • HIV/AIDS
    • Arsenic Trioxide
    • Guangzhou, Guangdong, China
      Guangzhou 8th People's Hospital
    Jul 19, 2021

    Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV

    Recruiting
    • HIV/AIDS
    • No intervention
    • Rome, Italy
      Infectious Dermatology STI Unit San Gallicano Dermatologic Insti
    Mar 23, 2022

    HIV-1-infection Trial in Liège (Dolutegravir 50 MG)

    Recruiting
    • HIV-1-infection
    • Dolutegravir 50 MG
    • Liège, Belgium
      Liège university hospital
    Apr 27, 2022

    HIV-1-infection Trial in Nairobi

    Recruiting
    • HIV-1-infection
      • Nairobi, Kenya
        Kenya Medical Research Institute
      Jul 19, 2021

      HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)

      Not yet recruiting
      • HIV-1-infection
      • HIV Seropositivity
      • Leucapheresis
      • Gent, Oost-Vlaanderen, Belgium
        UZ Gent
      Jul 25, 2023

      HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

      Withdrawn
      • HIV Infection
      • Analytical Treatment Interruption + bNAbs infusion
      • Milan, Lombardy, Italy
      • +3 more
      Aug 2, 2022

      HIV Trial in Puerto Rico, United States (Emtricitabine, Enfuvirtide, Ritonavir)

      Completed
      • HIV Infections
      • Aurora, Colorado
      • +6 more
      Oct 28, 2021

      ex Vivo Cure Studies With Chronic HIV Infected the Netherlands

      Recruiting
      • HIV Infections
      • +2 more
        • Rotterdam, Netherlands
          Erasmus MC
        Jul 26, 2022

        Quantification of Antisense HIV RNA in Patients

        Recruiting
        • HIV-1-infection
        • Blood sampling
        • Paris, France
          Jean-Paul VIARD
        Dec 21, 2022

        HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)

        Active, not recruiting
        Has Results
        • HIV
        • Combination Antiretroviral Therapy (cART)
        • +4 more
        • Brighton, United Kingdom
        • +5 more
        Aug 24, 2021

        HIV-1 Trial in Bethesda, New York (3BNC117-LS, 10-1074-LS, Sterile Saline)

        Recruiting
        • HIV-1
        • 3BNC117-LS
        • +2 more
        • Bethesda, Maryland
        • +1 more
        Jan 31, 2023

        HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)

        Recruiting
        • HIV-1-infection, Subtype b
        • Decitabine cycle 1
        • +7 more
        • Bruxelles, Belgium
        • +2 more
        Jan 30, 2023

        Tuberculosis, Pulmonary Trial in Godoy Cruz (RUTI® Vaccine, Placebo)

        Not yet recruiting
        • Tuberculosis, Pulmonary
        • RUTI® Vaccine
        • Placebo
        • Godoy Cruz, Mendoza, Argentina
          Hospital José Nestor Lencinas
        Jul 26, 2022

        HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))

        Active, not recruiting
        • HIV Infections
        • Treatment simplification (dolutegravir lamivudine)
        • Liège, Belgium
          Liège university hospital
        Apr 27, 2022